Answers are grounded in this paper and cite their sources.
Estrogen receptor-α (ERα) is a 66 kDa (ERα66) nuclear receptor transcription factor and it functionally plays a crucial role in various processes associated with human breast cancer.36 kDa novel variant of ERα66 has been identified and cloned, and named as ERα36.As reported previously, we observed a downregulation of ERα66 expression and an elevation of ERα36 levels in tamoxifen-resistant breast cancer (TAMR-MCF-7) compared to the parental MCF-7 cells.We investigated the functional roles of ERα66 and ERα36 and their potential mechanisms in regulating the epithelial-mesenchymal transition (EMT) process.Our findings revealed that the upregulation of ERα36 led to the downregulation of ERα66, consequently contributing to the acquisition of EMT and promoting metastasis.Furthermore, we explored the involvement of a long non-coding RNA (lncRNA) called homeobox transcript antisense intergenic RNA (HOTAIR) in the induction and regulation of EMT during metastasis.Interestingly, we observed that the increased expression of ERα36 resulted in elevated HOTAIR levels, while upregulation of ERα66 or downregulation of ERα36 abolished HOTAIR expression.Functional depletion of HOTAIR significantly impaired EMT and cell migration in TAMR-MCF-7 cells.Collectively, our data demonstrate that ERα36 acts as a key regulator of EMT-driven metastasis in human breast cancer by directly modulating the long non-coding RNA HOTAIR.
No takes yet. Share an insight, caveat, or question.
Bui et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: